Publication | Open Access
Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy
21
Citations
35
References
2022
Year
PFKM drives novel molecular pathways in GBM, offering a translational path to a novel therapeutic paradigm.
| Year | Citations | |
|---|---|---|
Page 1
Page 1